Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis
暂无分享,去创建一个
G. Mora | R. Mai | L. Mazzini | T. Bachetti | G. Francolini | A. Micheli | C. Camana | D. Facchetti | M. Poloni | L. Agnoletti
[1] R. Ferrari,et al. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. , 1999, European heart journal.
[2] M. Bellomo,et al. Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. , 1998, European cytokine network.
[3] R. Ransohoff. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology , 1997, Journal of leukocyte biology.
[4] L. Colom,et al. Autoimmunity and ALS , 1996, Neurology.
[5] D. Aderka. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. , 1996, Cytokine & growth factor reviews.
[6] David W. Anderson,et al. Altered expression of bcl‐2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons , 1996, Annals of neurology.
[7] B. Gazzard,et al. Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα) , 1996, Journal of Neurological Sciences.
[8] E. Stefani,et al. Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease , 1995, Muscle & nerve.
[9] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[10] M. Schwartz,et al. Tumor necrosis factor facilitates regeneration of injured central nervous system axons , 1991, Brain Research.
[11] S. Appel,et al. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. , 1990, Archives of neurology.
[12] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[13] M. Gurney,et al. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. , 1984, The New England journal of medicine.
[14] F. Norris,et al. The administration of guanidine in amyotrophic lateral sclerosis , 1974, Neurology.
[15] P. Vassalli,et al. The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.